Canadian Cancer Trials Group Bulletins

General


Recent Publication

A meta-analysis, including Canadian Cancer Trials Group MA.5 -- Intensive CEF versus Standard CMF as Adjuvant
Therapy For Breast Carcinoma In Premenopausal Patients With Histologically-Involved Axillary Nodes, was recently published in The Lancet Oncology.

Di Leo A, Desmedt C, Bartlett JMS, Piette F, Ejlertsen B, Pritchard KI, Larsimont D, Poole C, Isola J, Earl H, Mouridsen H, O'Malley FP, Cardoso F, Tanner M, Munro A, Twelves CJ, Sotiriou C, Shepherd L, Cameron D, Piccart MJ, Buyse M. HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data. The Lancet Oncology 12: 1134-42, 2011.

http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2811%2970231-5/abstract?elsca1=ETOC-ONCOLOGY&elsca2=email&elsca3=segment